Contributors

James M. Anderson Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, U.S.A.

C. Andrew Boswell Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Gordon C. Brandt MDRNA, Inc., Bothell, Washington, U.S.A.

William G. Brodbeck Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, U.S.A.

Henry R. Costantino MDRNA, Inc., Bothell, Washington, U.S.A.

David Cregut Sequence/Structure Bioinformatics, Drug Discovery Informatics, Merck Serono International, Geneva, Switzerland

Rong Deng Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Mark S. Dennis Department of Antibody Engineering, Genentech, Inc., South San Francisco, California, U.S.A.

Steven Dinh Noven Pharmaceuticals, Inc., Miami, Florida, U.S.A.

Paul J. Fielder Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Diane Frank MDRNA, Inc., Bothell, Washington, U.S.A.

Amita Joshi Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Robert F. Kelley Departments of Antibody Engineering and Protein Engineering, Genentech, Inc., South San Francisco, California, U.S.A.

Leslie A. Khawli Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Cecile M. Krejsa Applied Pharmacology LLC, Seattle, Washington, U.S.A.

Cherry Lei Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Chingyuan Li MDRNA, Inc., Bothell, Washington, U.S.A.

Kedan Lin Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Puchun Liu Noven Pharmaceuticals, Inc., Miami, Florida, U.S.A.

Henry B. Lowman Department of Antibody Engineering, Genentech, Inc., South San Francisco, California, U.S.A.

Iftekhar Mahmood Office of Blood Review and Research, Center for Biological Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, U.S.A.

Maria Mitsi Departments of Biochemistry and Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.

Graham Molineux Hematology-Oncology Research, Amgen, Inc., Thousand Oaks, California, U.S.A.

Emmanuel Monnet Neurology and Autoimmune and Inflammatory Diseases, Stratified Medicine-Exploratory Medicine, Medical Sciences and Innovation, Merck Serono International, Geneva, Switzerland

Randall J. Mrsny Department of Pharmacy and Pharmacology, University of Bath, Bath, U.K.

Matthew A. Nugent Departments of Biochemistry and Ophthalmology, Boston University School of Medicine, and Department of Biomedical Engineering, Boston University, Boston, Massachusetts, U.S.A.

Wendy S. Putnam Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Steven C. Quay MDRNA, Inc., Bothell, Washington, U.S.A.

Anthony P. Sileno MDRNA, Inc., Bothell, Washington, U.S.A.

Jean L. Spencer Departments of Biochemistry and Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.

Stephen J. Szilvassy Hematology-Oncology Research, Amgen, Inc., Thousand Oaks, California, U.S.A.

Mike Templin MDRNA, Inc., Bothell, Washington, U.S.A.

Frank-Peter Theil Research and Early Development, Genentech, Inc., South San Francisco, California, U.S.A.

Arto Urtti Centre for Drug Research, University of Helsinki, Helsinki, Finland

Yik A. Yeung Department of Antibody Engineering, Genentech, Inc., South San Francisco, California, U.S.A.

In Vitro/In Vivo Correlations of Pharmacokinetics, Pharmacodynamics, and Metabolism for Hematologic Growth Factors and Cytokines

Graham Molineux and Stephen J. Szilvassy

Hematology-Oncology Research, Amgen, Inc., Thousand Oaks, California, U.S.A.

0 0

Post a comment